Vascular endothelial growth factor receptor

Acronym

Definition

VEGFR

Vascular Endothelial Growth Factor Receptor

References in periodicals archive	?		Acronyms browser	?		Full browser	?
IMC-1C11 is an investigational monoclonal antibody designed to target and block the Vascular Endothelial Growth Factor Receptor (VEGFR) known as KDR, on the surface of growing endothelial cells. IMCLONE ACHIEVES PATIENT ENROLLMENT MILESTONE IN TRIAL by Biotech Business Two important Sutent targets, vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) are expressed by many types of solid tumors and are thought to play a crucial role in angiogenesis, the process by which tumors acquire blood vessels, oxygen and nutrients needed for growth. Pfizer Discontinues Phase 3 Trial of Sutent[R] in Metastatic ... by Business Wire Two important SUTENT targets, vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), are expressed by many types of solid tumors and are thought to play a crucial role in angiogenesis, the process by which tumors acquire blood vessels, oxygen and nutrients needed for growth. Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in ... by Business Wire	VAS-F VAS-H VAS-I VAS-P VAS-S VAS-X VAS/CCOPE VAS8 VASA VASAB VASAG VASAP VASARI VASAT VASB VASBO VASC VASCAN VASCAR VASCD VASCI VASCIC VASCM VASCO VASCON Vascular endothelial growth factor receptor VASD VASDHS VASDIP VASDR VASE VASEA VASEP VASES VASF VASFAA VASG VASGBI VASH VASHPO VASI VASIE VASIMR VASIP/COSIG VASIS VASITE VASJ VASKhNIL VASL VASLA VASLE	vascular dementia Vascular Dementia of Binswanger Type Vascular Dilatation and Tortuosity Vascular disease Vascular disease Vascular disease Vascular Disease Foundation Vascular Disease of Plants Vascular Disease Program Vascular Disease Risk Factors vascular diseases vascular disorders of the proximal femur Vascular Ehlers-Danlos Syndrome vascular ejection sound vascular ejection sound vascular ejection sound vascular ejection sound Vascular Endothelial Cell Growth Factor Vascular Endothelial Cell Growth Factor-A Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular Endothelial Growth Factor B Vascular Endothelial Growth Factor C vascular endothelial growth factor C/D receptor Vascular Endothelial Growth Factor D Vascular Endothelial Growth Factor Neutralizing Antibody Vascular endothelial growth factor receptor Vascular Endothelial Growth Factor Receptor 1 Vascular Endothelial Growth Factor Receptor 2 Vascular Endothelial Growth Factor Receptor-2 Vascular endothelial growth factors Vascular endothelial growth factors Vascular Endothelial Growth Inhibitor Vascular Endothelial Hyperplasia Vascular Endothelial Junction-Associated Molecule Vascular Endothelial Surface Index Vascular Endothelial Surface Score Vascular Endothelial Zinc Finger 1 vascular endothelium Vascular Endothelium Fibrinolytic Activity vascular engorgement vascular engorgement vascular engorgement Vascular Epidermal Growth Factor vascular fasciculus vascular goiter vascular goiter vascular goiter vascular graft vascular graft vascular graft vascular graft vascular graft vascular grafts vascular grafts vascular grafts vascular hamartoma

References in periodicals archive

Acronyms browser

Full browser

IMC-1C11 is an investigational monoclonal antibody designed to target and block the Vascular Endothelial Growth Factor Receptor (VEGFR) known as KDR, on the surface of growing endothelial cells.

IMCLONE ACHIEVES PATIENT ENROLLMENT MILESTONE IN TRIAL by Biotech Business

Two important Sutent targets, vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) are expressed by many types of solid tumors and are thought to play a crucial role in angiogenesis, the process by which tumors acquire blood vessels, oxygen and nutrients needed for growth.

Pfizer Discontinues Phase 3 Trial of Sutent[R] in Metastatic ... by Business Wire

Two important SUTENT targets, vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), are expressed by many types of solid tumors and are thought to play a crucial role in angiogenesis, the process by which tumors acquire blood vessels, oxygen and nutrients needed for growth.

Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in ... by Business Wire